![Someit Sidhu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Someit Sidhu
Vorstandsvorsitzender bei
Izana Bioscience Ltd.
Vermögen: 24 Mio $ am 30.06.2026
Profil
Dr. Someit Sidhu, MD, is a Chief Executive Officer at Akaza Bioscience Ltd., a Chief Executive Officer at Izana Bioscience Ltd., a Chairman & Chief Executive Officer at JATT II Acquisition Corp., a Chairman & Chief Executive Officer at JATT Ventures LP, a Chief Executive Officer at Khanda Therapeutics LP and a Chief Executive Officer at Zenios Bioscience LLP.
Dr. Sidhu was previously employed as a Non-Independent Director by Zura Bio Ltd., a Chairman & Chief Executive Officer by JATT Acquisition Corp., and a Chief Business Officer by Pathios Therapeutics Ltd. He received his undergraduate degree from Oxford University Medical School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 3’994’290 ( 4.2% ) | 24 Mio $ | 30.06.2026 |
Aktive Positionen von Someit Sidhu
| Unternehmen | Position | Beginn |
|---|---|---|
Izana Bioscience Ltd.
 Izana Bioscience Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology activities | Vorstandsvorsitzender | 26.05.2017 |
Akaza Bioscience Ltd. | Vorstandsvorsitzender | 01.01.2019 |
Zenios Bioscience LLP | Vorstandsvorsitzender | - |
JATT Ventures LP | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Someit Sidhu
| Unternehmen | Position | Ende |
|---|---|---|
| ZURA BIO LIMITED | Gründer | 21.05.2026 |
Pathios Therapeutics Ltd.
 Pathios Therapeutics Ltd. BiotechnologyHealth Technology Engages in discovering and developing novel small molecule drugs | Gründer | 28.08.2019 |
| JATT ACQUISITION CORP | Vorstandsvorsitzender | - |
Ausbildung von Someit Sidhu
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
4
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Oxford University Medical School
 Oxford University Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Izana Bioscience Ltd.
Izana Bioscience Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology activities | Health Technology |
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Engages in discovering and developing novel small molecule drugs | Health Technology |
JATT Acquisition Corp.
 JATT Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
JATT Ventures LP | |
Akaza Bioscience Ltd. | |
Zenios Bioscience LLP | |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
Wählen Sie MarketScreener 
